# Increasing incidences of spinal fractures to drive the Osteoporosis Drugs Market
Author:  Pal Sinha, Barnali 
Author URL: https://financedigest.com/author/pal-sinha-barnali
Published: 2021-11-18
Category: Research Reports
Category URL: https://financedigest.com/category/research-reports
Meta Title: Global Osteoporosis Drugs Market: Growth and Trends
Meta Description: Discover the latest trends in the global osteoporosis drugs market with a focus on key participants and market insights. Learn more at bit.ly/3bYEiYm.
URL: https://financedigest.com/increasing-incidences-of-spinal-fractures-to-drive-the-osteoporosis-drugs-markethtml

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qst7v3003gwirgwqtxn8i8/images/research-report-1736837152904-compressed.jpg)

PersistenceMarketResearch states that the global osteoporosis drugs market will witness a **CAGR of over 4.5% between 2020 and 2030**.

**Market Snapshot**

The very first choice for osteoporosis are bisphosphonates. They are inclusive of Alendronate (Fosamax) – to be administered weekly; Risedronate (Actonel) – to be administered monthly or weekly; Ibandronate (Boniva) – quarterly intravenous (IV) infusion or monthly; and Zoledronic acid (Reclast), a yearly IV infusion; and denosumab (Xgeva, Prolia). The present-day research states that on not adhering to the prescribed intake of this drug, there could be a [higher risk](https://www.financedigest.com/dollar-higher-on-risk-aversion-euro-revisits-parity.html "Dollar higher on risk aversion; euro revisits parity") to spinal fractures. This factor is bound to go well with the osteoporosis [drugs market](https://www.financedigest.com/the-peptic-ulcer-drugs-market-to-proliferate-with-digitized-upswing.html "The Peptic Ulcer Drugs Market to proliferate with digitized upswing") in the years to come.

Plus, these days, intravenous bisphosphonates are preferred to the ones in pill form as they do not upset the stomach.

**Going Deeper**

Apart from bisphosphonates, the other products used as [osteoporosis drugs](https://www.financedigest.com/the-osteoporosis-drugs-market-to-supersede-based-on-innovation.html "The Osteoporosis Drugs Market To Supersede Based On Innovation") include calcitonin, parathyroid hormone therapy, SERM (Selective Estrogen Inhibitors Modulator), and rank ligand inhibitors. The drugs that help in bone-building include Romosozumab (Evenity), Abaloparatide (Tymlos), and Teriparadite (Forteo). They work wonders for the ones who are subject to osteoporosis due to steroids, or those who had fractures, or those who have lower bone density.

**Region-wise**

North America [holds the largest market share](https://www.financedigest.com/power-generation-sector-to-remain-largest-end-user-of-industrial-engines-persistence-market-research.html "Double Acting Hydraulic Cylinders to Hold Close to 50% Market Share: Persistence Market Research"). This could be reasoned with hoards of collaborations being worked upon by [companies for enhancing the research](https://www.financedigest.com/title-rubber-gloves-market-research-report-2030-top-companies-market-size-and-forecast.html "Rubber Gloves Market Research Report 2030: Top Companies, Market Size and Forecast") capabilities. Europe is second-seeded. The Asia-Pacific is expected to grow at the fastest rate between 2020 and 2030 due to companies making relentless efforts in commercializing generic and branded therapeutics, that too, taking affordability into consideration.

**Competitive Landscape**

The [key market](https://www.financedigest.com/sodium-tetraborate-market-key-players-end-user-demand-and-consumption-by-2030.html "Sodium Tetraborate Market Key Players, End User, Demand and Consumption by 2030") participants include **Merck & Co., F. Hoffmann La Roche Ltd., Teva Pharmaceutical Industries Ltd., Novo Nordisk, Pfizer Inc., Amgen Inc., and Novartis International AG. Raloxifene from Dr. Reddy’s has been received very well for treating osteoporosis. DUAVEE from Pfizer Inc**. comes across as a conjugated estrogen to treat/prevent post-menopausal osteoporosis. Also, Laboratorios Farmacéuticos Rovi, S.A. (ROVI), since Apr 2019, started [marketing Teva Pharmaceuticals’](https://www.financedigest.com/the-aquaculture-feed-and-pharmaceutical-market-to-move-ahead-on-rpa-robotic-process-automation.html "The Aquaculture Feed And Pharmaceutical Market to move ahead on RPA (Robotic Process Automation)") Tetridar for treating adults suffering from osteoporosis.

**To Know More about Report @** [**https://bit.ly/3bYEiYm**](https://bit.ly/3bYEiYm)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---